Director, Vice Chairman, Professor, Fox Chase Cancer Center,
Mathews Journal of Cancer Science (MJCS; ISSN 2474-6797) is a leading-edge open access journal on cancer science. This peer-reviewed scholarly journal has a huge international footprint and publishes in various areas related to cancer science, e.g., cancer biology; cancer genetics; tumorigenesis; cancer progression and metastasis; preclinical, clinical, and epidemiological, treatments of different cancers, like lymphoma, sarcoma, gynecological cancer, brain tumor, colon cancer, and lung cancer. MJCS welcomes both theoretical and clinical contributions in the form of research articles, reviews, case reports, editorials, and communications. This journal serves as a high-profile forum for promoting major advances in oncology and cancer research.
MJCS primarily considers manuscripts for publication based on whether the findings of the studies can enable answering important questions relevant to naturally occurring cancers and provide information that serves as a foundation for future advancements in cancer research. This journal serves as a source of credible and authoritative information regarding all aspects of this debilitating disease that imposes both economic- and health-related burdens on individuals as well as the society.
Benefits for authors
High Visibility: Mathews Journal of Cancer Science (MJCS) follows open access policy that allows the published articles in the journal will reach across the globe.
Promotion in Social Media: Once the article is published online, we provide article alerts and regular email updates to subscribers through our social media platforms.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Cancer Science. For submission assistance contact: [email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at [email protected] or call us at +1-606-405–6566
Published : 27th January 2023
Authors : Gashaw Arega1*, Daniel Hailu1, Abdulkadir Mohammedsaid Gidey1, Abel Hailu1, Mulualeme Nigusie1, Getasew Fikad1, Sewagegnh Yeshiwas2, Abrehet Zeray3, Samuel Sisay3
Citation : Arega G, et al. (2023). A Rare Case of Childhood Adrenocortical Carcinoma in a 4-Years-Old Female Child Presented with Features of Cushing Syndrome: Case Report and Literature Review. Mathews J Cancer Sci. 8(1):36.
Published : 17th October 2022
Authors : Motohiro Chosokabe1,2* Yasushi Ariizumi1,2 and Junki Koike1
Citation : Chosokabe M, et al. (2022). Remote Rapid Intraoperative Diagnosis Support System Using the Remote Desktop. Mathews J Cancer Sci. 7(3):35.
Published : 22nd September 2022
Author : Leslie C Costello, PhD*
Citation : Costello LC. (2022). The Genetic Evolution of “Decreased Zinc” Malignancies and Their Treatment. Mathews J Cancer Sci. 7(3):34.
Published : 26th July 2022
Authors : Safa Al Shaikh*, Aalaa S. Shubbar
Citation : Al Shaikh S, et al. (2022). Evaluation and Analysis of Colon Cancer in Kingdom of Bahrain: A Retrospective Study in a Tertiary Care Center. Mathews J Cancer Sci. 7(2):32.
Published : 26th July 2022
Authors : T Dos-Santos1*, D Cvetkovic1, L Chen1, S Liu2, M Li2, L Yang2, D Wu3, and CM Ma1
Citation : Dos Santos T, et al. (2022). Investigation of Dose-Rate Effects in Pulsed Low Dose Rate Radiotherapy. Mathews J Cancer Sci. 7(2):33.
Published : 03rd June 2022
Authors : Huan Liu1, Chenyang Shen2, Peter Klages2, Kevin Albuquerque2, Chang M Ma1*, Xun Jia2*
Citation : Chang-Ming Ma, Xun Jia, et al. (2022). Interactive Treatment Planning in High Dose-Rate Brachytherapy for Gynecological Cancer. Mathews J Cancer Sci. 7(2):31.